Meeting The Challenge Of Diversity And Inclusion In Clinical Trials Improving representation in clinical trials and research: building research equity for women and underrepresented groups. washington, dc: national academies press, 2022. google scholar. All members of society need to be represented in medical research, but there is major under representation of racial and ethnic minorities in clinical trials.1 the national institutes of health (nih) revitalization act was created in 1993 to increase the inclusion of diverse populations in clinical research to decrease health care disparities.2 even though the 2018 us census bureau population.
Minorities Are Underrepresented In Clinical Trials Aafp Racial and ethnic minorities are underrepresented in clinical research. this is a concern because people of different ages, races, and ethnicities, may react differently to medical products. Clinical trials primarily enroll white, male patients, with consistent underrepresentation of women, the elderly, and people of color — especially black and hispanic patients. The paucity of diversity in clinical trials generates a racial ethnic data gap that skews medical evidence and innovation towards therapies with understudied efficacy and safety for minority populations. 2, 6 data generated from investigations that lack racial ethnic diversity formalize a biased framework of “normal” and “diseased. Insufficient demographic diversity in clinical trials has long been recognized as an issue that may hinder innovation and access to therapies. in the past three decades, however, diversity in clinical trials became a policy priority, advanced by federal agencies such as the food and drug administration (fda) office of women’s health and the society for women’s health research (swhr), and.
Pdf Minorities Are Underrepresented In Clinical Trials Of The paucity of diversity in clinical trials generates a racial ethnic data gap that skews medical evidence and innovation towards therapies with understudied efficacy and safety for minority populations. 2, 6 data generated from investigations that lack racial ethnic diversity formalize a biased framework of “normal” and “diseased. Insufficient demographic diversity in clinical trials has long been recognized as an issue that may hinder innovation and access to therapies. in the past three decades, however, diversity in clinical trials became a policy priority, advanced by federal agencies such as the food and drug administration (fda) office of women’s health and the society for women’s health research (swhr), and. Despite the regulatory efforts to increase gender diversity in trial enrollment, evidence from the 1990s and early 2000s suggested relative underrepresentation of women and racial and ethnic minority population groups in clinical trials (cotton, 1990; harris and douglas, 2000; mak et al., 2007; murthy et al., 2004), which persisted until 2016. In a clinical trial exploring barriers and motivators to participation in clinical trials among 67 black americans, focus group themes included the perception that research would benefit white participants or the research institution more so than any underrepresented individuals enrolling in the study (belue et al., 2006).
Improving The Representation Of Women And Underrepresented Minorities Despite the regulatory efforts to increase gender diversity in trial enrollment, evidence from the 1990s and early 2000s suggested relative underrepresentation of women and racial and ethnic minority population groups in clinical trials (cotton, 1990; harris and douglas, 2000; mak et al., 2007; murthy et al., 2004), which persisted until 2016. In a clinical trial exploring barriers and motivators to participation in clinical trials among 67 black americans, focus group themes included the perception that research would benefit white participants or the research institution more so than any underrepresented individuals enrolling in the study (belue et al., 2006).
Improving The Representation Of Women And Underrepresented Minorities
Minorities Are Severely Underrepresented In Clinical Trials Igi Global
Comments are closed.